You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

matched related donor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia

Recruiting
  • Acquired Aplastic Anemia
  • +2 more
  • CliniMACs
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 1, 2022

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

Completed
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 16, 2021

Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm
  • +2 more
  • Decidual stromal cells (DSC)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with

Recruiting
  • Bone Marrow Failure Syndromes
  • MRD-BMT with Fludarabine-based RIC for Acquired AA
  • +2 more
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 6, 2022

Hematologic Malignancies Trial in Milwaukee (CliniMACs)

Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Apr 4, 2022

Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Enrolling by invitation
  • Severe Combined Immune Deficiency (SCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • Haploidentical hematopoietic cell transplantation (haploHCT)
  • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
  • (no location specified)
Jul 13, 2022

Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

Available
  • Leukemia
  • +2 more
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 2, 2021

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Myeloid Malignancies, Lymphoid Malignancies Trial in Durham (NK Cell enriched-DLI only, NK-DLI + DUK-CPG-001)

Recruiting
  • Myeloid Malignancies
  • Lymphoid Malignancies
  • NK Cell enriched-DLI only
  • NK-DLI + DUK-CPG-001
  • Durham, North Carolina
    Duke University Health System
Mar 8, 2022

Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

Completed
  • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
  • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
  • CliniMACS (CD+3, CD+19 depletion)
  • +2 more
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Oct 21, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)

Completed
  • Multiple Myeloma
  • Amyloidosis
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 24, 2021

High Risk Hematologic Malignancies Trial in Salt Lake City (stem cell transplant, Stem cell transplant)

Terminated
  • High Risk Hematologic Malignancies
  • stem cell transplant
  • Stem cell transplant
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 10, 2020

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

Not yet recruiting
  • Severe Aplastic Anemia
  • (no location specified)
Oct 1, 2023

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)

Recruiting
  • Sickle Cell Disease
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jul 31, 2022